Intech Investment Management LLC Acquires New Shares in Genpact Limited (NYSE:G)

Intech Investment Management LLC acquired a new position in shares of Genpact Limited (NYSE:GFree Report) in the 4th quarter, HoldingsChannel.com reports. The fund acquired 134,655 shares of the business services provider’s stock, valued at approximately $5,783,000.

A number of other institutional investors also recently bought and sold shares of G. SRH Advisors LLC acquired a new position in shares of Genpact during the 4th quarter worth $26,000. Manchester Capital Management LLC purchased a new position in Genpact during the 4th quarter valued at about $38,000. Smartleaf Asset Management LLC raised its position in Genpact by 416.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider’s stock worth $41,000 after acquiring an additional 783 shares during the last quarter. UMB Bank n.a. raised its position in Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock worth $52,000 after acquiring an additional 433 shares during the last quarter. Finally, J.Safra Asset Management Corp grew its position in shares of Genpact by 38.8% in the fourth quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider’s stock valued at $69,000 after purchasing an additional 453 shares during the last quarter. 96.03% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

G has been the subject of several research reports. Needham & Company LLC lifted their price objective on Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Mizuho raised their price target on Genpact from $45.00 to $55.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. TD Cowen upgraded Genpact from a “hold” rating to a “buy” rating and upped their price objective for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Finally, Jefferies Financial Group upgraded Genpact from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $44.00 to $55.00 in a research report on Tuesday, January 21st. Six analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, Genpact has a consensus rating of “Hold” and an average target price of $48.44.

Check Out Our Latest Analysis on Genpact

Insider Buying and Selling

In other news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the sale, the chief executive officer now owns 310,246 shares of the company’s stock, valued at $15,167,926.94. This represents a 4.20 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Piyush Mehta sold 12,000 shares of Genpact stock in a transaction on Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the transaction, the senior vice president now owns 151,182 shares in the company, valued at $6,475,125.06. The trade was a 7.35 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.80% of the company’s stock.

Genpact Stock Performance

NYSE G opened at $50.47 on Wednesday. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $8.87 billion, a PE ratio of 17.77, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. The business’s 50-day moving average price is $49.86 and its 200 day moving average price is $44.46. Genpact Limited has a twelve month low of $30.23 and a twelve month high of $56.76.

Genpact (NYSE:GGet Free Report) last released its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. On average, research analysts predict that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.35%. This is an increase from Genpact’s previous quarterly dividend of $0.15. The ex-dividend date is Tuesday, March 11th. Genpact’s dividend payout ratio is presently 23.94%.

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Stories

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.